OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 75 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,000 | +124.0% | 4,508 | +60.9% | 0.00% | – |
| Q2 2023 | $25,000 | +2400.0% | 2,801 | +682.4% | 0.00% | – |
| Q1 2023 | $1,000 | – | 358 | +336.6% | 0.00% | – |
| Q4 2022 | $0 | – | 82 | +10.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 74 | -95.3% | 0.00% | – |
| Q1 2022 | $7,000 | -99.4% | 1,576 | -98.7% | 0.00% | – |
| Q4 2021 | $1,120,000 | +1477.5% | 119,687 | +4522.9% | 0.00% | – |
| Q3 2021 | $71,000 | +82.1% | 2,589 | +85.1% | 0.00% | – |
| Q2 2021 | $39,000 | +5.4% | 1,399 | +27.1% | 0.00% | – |
| Q1 2021 | $37,000 | – | 1,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |